Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites-Reference-Cited by-同舟云学术

Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites

Published:2015-12 Issue:6 Volume:30 Page:425-433
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Zhou Xiaotong,Wang Shaoxiang,Sun Hua,Wu Baojian

Funder

Young Scientist Special Projects in Biotechnological And Pharmaceutical field of 863 Program

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference45 articles.

1. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification;Rowland;Int J Biochem Cell Biol,2013

2. Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation;Klaassen;FASEB J,1997

3. Structural and chemical profiling of the human cytosolic sulfotransferases;Allali-Hassani;PLoS Biol,2007

4. Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility;Chapman;Angew Chem Int Ed Engl,2004

5. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily;Blanchard;Pharmacogenetics,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New potential selective estrogen receptor modulators in traditional Chinese medicine for treating menopausal syndrome;Phytotherapy Research;2024-08-09

2. Comparative Pharmacokinetic Profiles of a Novel Low‐Dose Micronized Formulation of Raloxifene 45 mg (AD‐101) and the Conventional Raloxifene 60 mg in Healthy Subjects;Clinical Pharmacology in Drug Development;2023-08-25

3. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients;Acta Pharmaceutica Sinica B;2023-01

4. The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates;Frontiers in Pharmacology;2022-01-13

5. Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers;Clinical Pharmacology in Drug Development;2022-01-04